PubRank

O Amengual

Author PubWeight™ 23.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol 1998 1.54
2 Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost 1997 1.52
3 Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis. Lupus 2005 1.51
4 Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. Br J Rheumatol 1998 1.14
5 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 2011 1.13
6 Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. Arthritis Rheum 1999 1.11
7 Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. Arthritis Rheum 1998 1.04
8 Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis 2008 1.03
9 Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study. Ann Rheum Dis 2006 0.88
10 Correlation between beta2-glycoprotein I valine/leucine247 polymorphism and anti-beta2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome. Rheumatology (Oxford) 1999 0.86
11 Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. J Rheumatol 1998 0.84
12 Association of HLA-DM polymorphism with the production of antiphospholipid antibodies. Ann Rheum Dis 2004 0.83
13 HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology (Oxford) 2001 0.82
14 Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement. Rheumatology (Oxford) 2003 0.82
15 Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. Clin Exp Rheumatol 2000 0.82
16 Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium. Rheumatology (Oxford) 2003 0.81
17 Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. J Rheumatol 1998 0.81
18 Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system. Clin Exp Immunol 1998 0.81
19 Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. J Rheumatol 1999 0.81
20 Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome. Lupus 2012 0.80
21 Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. Br J Rheumatol 1998 0.79
22 Association of antiphosphatidylserine/prothrombin autoantibodies with HLA class II genes. Arthritis Rheum 2000 0.79
23 Thrombotic microangiopathy in patients with phosphatidylserine dependent antiprothrombin antibodies and antiphospholipid syndrome. Clin Exp Rheumatol 2008 0.78
24 Prothrombin mutation is not associated with thrombosis in patients with antiphospholipid syndrome. Thromb Haemost 1998 0.77
25 Fcgamma receptor IIA H/R131 polymorphism in patients with antiphospholipid antibodies. Thromb Haemost 1998 0.77
26 IgG2 restriction of anti-beta2-glycoprotein I as the basis for the association between IgG2 anticardiolipin antibodies and thrombosis in the antiphospholipid syndrome: comment on the article by Sammaritano et al. Arthritis Rheum 1998 0.75
27 Most anticardiolipin antibodies in mixed connective tissue disease are beta2-glycoprotein independent. J Rheumatol 1998 0.75
28 The involvement of CD36 in monocyte activation by antiphospholipid antibodies. Lupus 2013 0.75
29 An evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of arterial thrombosis in patients with the antiphospholipid syndrome. Arthritis Rheum 2000 0.75